Description and Brand Names

Información sobre medicamentos proporcionada por: IBM Micromedex

US Brand Name

  1. Zydelig


Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL). This medicine is also used to treat follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL) in patients who have received at least two previous treatments. Idelalisib interferes with the growth of cancer cells, which are eventually destroyed by the body. It is an antineoplastic agent (cancer medicine).

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Tablet